---
id: ITE-2022-032
type: ITE
year: 2022
number: 32
created: 2025-08-08 07:54:57.694903
tags:
- ITE
- question
- ITE-2022
answer: D
topic: null
related_articles:
- title: Chronic Rhinosinusitis.
  path: 2023/2023-10-chronic-rhinosinusitis.md
  similarity: 0.4
  link: '[[2023/2023-10-chronic-rhinosinusitis|Chronic Rhinosinusitis.]]'
- title: 'Chronic Obstructive Pulmonary Disease: Diagnosis and Management.'
  path: 2023/2023-06-chronic-obstructive-pulmonary-disease-diagnosis-and-manageme.md
  similarity: 0.391
  link: '[[2023/2023-06-chronic-obstructive-pulmonary-disease-diagnosis-and-manageme|Chronic
    Obstructive Pulmonary Disease: Diagnosis and Management.]]'
- title: Caution Before Antibiotic De-escalation Following Negative MRSA Nares Testing.
  path: 2022/2022-10-caution-before-antibiotic-de-escalation-following-negative-m.md
  similarity: 0.389
  link: '[[2022/2022-10-caution-before-antibiotic-de-escalation-following-negative-m|Caution
    Before Antibiotic De-escalation Following Negative MRSA Nares Testing.]]'
- title: 'Conjunctivitis: Diagnosis and Management.'
  path: 2024/2024-08-conjunctivitis-diagnosis-and-management.md
  similarity: 0.375
  link: '[[2024/2024-08-conjunctivitis-diagnosis-and-management|Conjunctivitis: Diagnosis
    and Management.]]'
- title: 'Chronic Cough: Evaluation and Management.'
  path: 2024/2024-08-chronic-cough-evaluation-and-management.md
  similarity: 0.346
  link: '[[2024/2024-08-chronic-cough-evaluation-and-management|Chronic Cough: Evaluation
    and Management.]]'
topics:
- ENT
- Nasal Congestion
- Palliative Care
- Pharmacology
- Pulmonology
- Quality Of Life
related_articles_2023_2025:
- title: afp clinical answers
  path: 2024/10/2024-10-afp-clinical-answers.md
  similarity: 0.313
  link: '[[2024/10/2024-10-afp-clinical-answers|afp clinical answers]]'
- title: afp clinical answers
  path: 2023/12/2023-12-afp-clinical-answers.md
  similarity: 0.31
  link: '[[2023/12/2023-12-afp-clinical-answers|afp clinical answers]]'
- title: cochrane corticosteroids asthma
  path: 2023/08/2023-08-cochrane-corticosteroids-asthma.md
  similarity: 0.308
  link: '[[2023/08/2023-08-cochrane-corticosteroids-asthma|cochrane corticosteroids
    asthma]]'
- title: editorial sore throat
  path: 2024/04/2024-04-editorial-sore-throat.md
  similarity: 0.307
  link: '[[2024/04/2024-04-editorial-sore-throat|editorial sore throat]]'
- title: prenatal care
  path: 2023/08/2023-08-prenatal-care.md
  similarity: 0.305
  link: '[[2023/08/2023-08-prenatal-care|prenatal care]]'
last_updated: '2025-08-10T20:25:20.647295'
---

# Question ITE-2022-032

nasal congestion, watery eyes, sneezing, and cough. He reports that he always has similar symptoms this time of year. He has tried taking over-the-counter diphenhydramine (Benadryl Allergy) for the past week but finds it too sedating. He reports that his symptoms are interfering with his quality of life. On examination he has pale, boggy nasal mucosa with clear rhinorrhea. Lung auscultation is normal. Which one of the following is the most appropriate treatment?

## Options

**A.** Butterbur herbal supplement

**B.** Oral amoxicillin

**C.** Oral montelukast (Singulair)

**D.** Intranasal fluticasone (Flonase Allergy Relief)

**E.** Intramuscular methylprednisolone

## Answer

**D**

## Explanation

This patient has signs and symptoms of seasonal allergic rhinitis. He has a history of seasonal symptoms
with a predominance of itchy nose, clear rhinorrhea, and watery eyes. The American Academy of Allergy,
Asthma & Immunology (AAAA&I) Rhinitis 2020 practice parameter update recommends an intranasal
corticosteroid such as fluticasone as initial treatment for seasonal allergic rhinitis (SOR strong, certainty
of evidence (see [[Articles/2023/2023-05-diabetes-management-primary-care.md|Diabetes Management in Primary Care: Evidence-Based Approaches]]) [COE] high). Due to the lack of available evidence, the AAAA&I cannot make a
recommendation for or against the use of herbal treatments such as butterbur or Yu ping feng san. An oral
antibiotic such as amoxicillin would be used for suspected bacterial infectious rhinitis, which this patient
does not have. The AAAA&I suggests not using the leukotriene receptor antagonist montelukast as initial
treatment due to its decreased efficacy when compared to other treatments (SOR conditional, COE very
low). Furthermore, the FDA has advised that, due to the risk of serious neurops...



## Related Articles

- [[Articles/2023/2023-05-diabetes-management-primary-care.md|Diabetes Management in Primary Care: Evidence-Based Approaches]]

## References

*[To be added from answer key]*
